Traditional Chinese medicine composition for treating rheumatism and preparation method thereof

Abstract

The invention especially relates to a traditional Chinese medicine composition for treating rheumatism and a preparation method thereof, belonging to the field of traditional Chinese medicine preparations. The traditional Chinese medicine composition is prepared from the following substances by weight: 1.2 to 4.5 parts of agkistrodon, 3.6 to 13.5 parts of Radix Notoginseng, 3.5 to 12.8 parts of Rhizoma Drynariae, 5.6 to 22.5 parts of Radix Dipsaci, 3.8 to 14.2 parts of Semen Strychni Preparata, 2.4 to 5.8 parts of clematis roots, 1.5 to 4.6 parts of Radix Angelicae Pubescentis, 3.5 to 7.4 parts of honeysuckle flowers, 5.2 to 9.5 parts of Chinese angelica roots and 4.2 to 8.6 parts of buck grass. The traditional Chinese medicine composition provided by the invention is capable of dispellingwind, eliminating dampness, activating blood circulation to dissipate blood stasis, promoting reunion of fractured bones and relaxing muscles and tendons to relieve pain, and mainly treats rheumaticpain in the waist and lower extremities, lumbar disc herniation and sciatica; and during treatment, the traditional Chinese medicine composition has the beneficial effects of fast action, little pain,short treatment course, small toxic and side effect, etc.

Description

technical field

[0001] The technical field of traditional Chinese medicine medicaments of the present invention, in particular, relates to a traditional Chinese medicine composition for treating rheumatism and a preparation method thereof. Background technique

[0002] Rheumatism is a group of diseases mainly invading joints, bones, muscles, blood vessels and related soft or connective tissues, most of which are autoimmune diseases. The onset is mostly hidden and slow, the course of the disease is long, and most of them have genetic predisposition. Diagnosis and treatment are difficult; different autoantibodies can be detected in the blood, which may be related to different HLA subtypes; there is a good short-term response to non-steroidal anti-inflammatory drugs (NSAIDs), glucocorticoids and immunosuppressants or long-term remission. At present, for the treatment of rheumatism, especially rheumatic low back pain, lumbar disc herniation, sciatica and other diseases, the us...